Litcius/Paper detail

Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations

Matthias Scheffler, Alessandra Holzem, Anna Kron, Lucia Nogová, Michaela A. Ihle, Cornelia von Levetzow, Jana Fassunke, C. Wömpner, Elisabeth Bitter, Sophia Koleczko, Diana S.Y. Abdulla, Sebastian Michels, Rieke Fischer, Richard Riedel, Jan-Philipp Weber, Theresa Westphal, Ulrich Gerigk, Jens Kern, Britta Kaminsky, Winfried Randerath, K Kambartel, Sabine Merkelbach‐Bruse, Reinhard Büttner, Jürgen Wolf

2020Lung Cancer24 citationsDOI

Topics & Concepts

MedicineMutationLung cancerCancer researchAdenocarcinomaV600EROS1OncologyCancerInternal medicineGeneGeneticsBiologyMelanoma and MAPK PathwaysLung Cancer Treatments and MutationsCancer Mechanisms and Therapy
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations | Litcius